SFDA approves first gene therapy for sickle cell anemia and thalassemia ...Saudi Arabia

ٍٍٍSaudi Gazette - News
SFDA approves first gene therapy for sickle cell anemia and thalassemia
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has approved Casgevy, the first gene therapy for sickle cell anemia and thalassemia diseases in patients 12 years of age and older.It

Hence then, the article about sfda approves first gene therapy for sickle cell anemia and thalassemia was published today ( ) and is available on ٍٍٍSaudi Gazette ( Saudi Arabia ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SFDA approves first gene therapy for sickle cell anemia and thalassemia )

Apple Storegoogle play

Last updated :

Also on site :